By signal seeking Phase II studies, we mean studies to evaluate the safety signals, when bavituximab is given along with different chemotherapeutic agents in advanced breast and lung cancer patients.
"To evaluate the safety signals..."
Folks, safety is a phase I evaluation metric, not phase II.